Research has led to progress against many types of cancer:

• Better Treatments
• a Lower Chance of Death from the Disease
• and Improved Quality of Life.

Through research, knowledge about cancer keeps increasing. Scientists are learning more about what causes cancer and are finding new ways to prevent, detect, diagnose, and treat this disease.

Highlands Oncology Group, PA has been participating in clinical trials for over 15 years. The research department started with a small staff of one who performed all duties. Today, our current staff includes a Research Director, 2 Phase I Coordinators, 5 Phase II/III/IV Coordinators, 2 Medical Assistants, 3 Data Managers, and 3 Regulatory Specialist. Typically there are 25-35 open and accruing trials with 3-5 more pending. The trials cover a variety of cancer diagnoses. Highlands Oncology Group, PA has the privilege of being the only community Phase I Oncology clinical site in the state of Arkansas.

Clinical trials are a treatment option for many people living with cancer. The next few pages may help to explain clinical trials and give you something to think about when deciding whether or not to participate.

All Categories BREASTCERVICALCOLONCOLORECTALGLIOBLASTOMAHEAD/NECKHEAD/NECK - EsophagealHEAD/NECK - LaryngealLEUKEMIALEUKEMIA - Acute LymphoblasticLEUKEMIA - Acute MyeloidLEUKEMIA - Chronic LymphocyticLEUKEMIA - Chronic MyelogenousLIVERLUNGLUNG - Non Small Cell Cancer (NSCLC)LUNG - Small Cell Cancer (SCLC)LYMPHOMALYMPHOMA - HodgkinsLYMPHOMA - Non Hodgkins (NHL)MELANOMAMULTIPLE MYELOMAOTHEROVARIANPANCREATICPROSTATERECTALRENAL CELLTESTICULARTHYROIDWALDENSTROM MACROGLOBULINEMIA

I5B-MC-JGDP	PANCREATIC	10/23/2018	View Here
WO40181 Breast Cancer, ER+, HER2-Locally advanced or Metastatic	BREAST	10/23/2018	View Here
Tyme-88-Panc Pancreatic Cancer	PANCREATIC	10/23/2018	View Here
Platinum Resistant or Refractory Ovarian Cancer	OVARIAN	10/23/2018	View Here
CPDR001F2301 Melanoma-Unresectable or Metastatic	MELANOMA	10/23/2018	View Here
CPDR001C2101 NSCLC- stage IIIB or IV	LUNG - Non Small Cell Cancer (NSCLC)	10/23/2018	View Here
B9991025 ADV/MET SOLID TUMOR	OTHER	10/23/2018	View Here
I3Y-MC-JPCF BREAST CANCER HR+, HER2 -, high risk, node+, early stage, resected	BREAST	10/23/2018	View Here
C16029 Relapsed/Refractory Multiple Myeloma	MULTIPLE MYELOMA	10/23/2018	View Here
D419QC00001(Caspian) SCLC Stage IV	LUNG - Small Cell Cancer (SCLC)	10/23/2018	View Here
I3Y-MC-JPBH Breast –Metastatic-Phase 1	BREAST	10/23/2018	View Here
RXDX-101-02 ( STARTRK-2) Locally Advanced Tumors	OTHER	10/23/2018	View Here
M16-298 (MERU) Extensive Stage SCLC - Maintenance	LUNG - Small Cell Cancer (SCLC)	10/23/2018	View Here
G1T28-03 SCLC Extensive-Stage , 2nd or 3rd line Tx	LUNG - Small Cell Cancer (SCLC)	10/23/2018	View Here
M16-289 (TAHOE) Advanced or Metastatic DLL3high SCLC – 2nd Line	LUNG - Small Cell Cancer (SCLC)	10/23/2018	View Here
CX-839-005 Renal Cell Carcinoma – Advanced or Metastatic	RENAL CELL	10/23/2018	View Here
CA 209914 “CheckMate 914” Renal Cell Carcinoma – Previously Untreated, Localized Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse.	RENAL CELL	10/23/2018	View Here
I3Y-MC-JPCE NSCLC KRAS and PDL1 positive, stage IV	BREAST	10/23/2018	View Here
GO29527 NSCLC - Stage IB−Stage IIIA	LUNG - Non Small Cell Cancer (NSCLC)	10/23/2018	View Here
CA209592 NSCLC-Stage IV	LUNG - Non Small Cell Cancer (NSCLC)	10/23/2018	View Here
VX15/2503-04 NSCLC – Stage IV	LUNG - Non Small Cell Cancer (NSCLC)	10/23/2018	View Here
SWOG S1320 MUTANT MELANOMA	MELANOMA	10/23/2018	View Here
CO39722 UNTREATED ADVANCED WILD-TYPE MELANOMA	MELANOMA	10/23/2018	View Here
UTX-TGR-204 Lymphocytic Leukemia- Chronic	LEUKEMIA - Chronic Lymphocytic	10/23/2018	View Here
BBI-DSP7888-201G Recurrent or Progressive Glioblastoma	GLIOBLASTOMA	10/23/2018	View Here
LSK-AM301 Advanced or Metastatic Gastric Cancer	OTHER	10/23/2018	View Here
CLEE011XUS29 HR+ HER2- Breast Cancer	BREAST	10/23/2018	View Here
SWOG S1418 TNBC with Residual Invasive Cancer	BREAST	10/23/2018	View Here
MM-121-02-02-10 (SHERBOCK) BREAST CANCER-locally advanced or metastatic. ER/PR (+), HER2(-), Heregulin(+).	BREAST	10/23/2018	View Here
BMS CA209-602 Multiple Myeloma Relapsed Or Refractory	MULTIPLE MYELOMA	10/23/2018	View Here
CA209-592 NSCLC Stage IV	LUNG - Non Small Cell Cancer (NSCLC)	10/23/2018	View Here
WO30070 UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA	OTHER	10/23/2018	View Here
4010-01-001 Advanced solid Tumors	OTHER	10/23/2018	View Here
CANSTEM 111P Pancreatic Adenocarcinoma	PANCREATIC	10/23/2018	View Here
CO39262 Melanoma	MELANOMA	10/23/2018	View Here
BDX-00146 (INSIGHT)	LUNG - Non Small Cell Cancer (NSCLC)	10/23/2018	View Here
B9991016 Head and Neck, Stage IV,Squamous cell, locally advanced, high risk carcinoma of oral cavity, larynx, hypopharynx, oropharynx.	HEAD/NECK	10/23/2018	View Here
I4D-MC-JTJH SCLC Previously Treated Extensive Stage	LUNG - Small Cell Cancer (SCLC)	10/23/2018	View Here
“Vaccination of High Risk Breast Cancer Patients”	BREAST	10/23/2018	View Here
HALO 109-301 Pancreatic	PANCREATIC	10/23/2018	View Here
GU 115 / I6A-MC-CBBD Metastatic Castration Resistant Prostate Cancer	PROSTATE	10/23/2018	View Here
ML28897-PRO02 Pathway Activated Solid Tumors	OTHER	10/23/2018	View Here